These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 30056139)
41. Cannabinoids and cancer pain: some considerations. Vargas Mondaca A Medwave; 2016 Nov; 16(10):e6597. PubMed ID: 27922583 [No Abstract] [Full Text] [Related]
42. Comprehensive Targeted Treatment for Neuropathic and Nociceptive Pain in Palliative Care Patients. Mihailescu-Marin MM; Mosoiu DV; Dima L Am J Ther; 2022 Sep-Oct 01; 29(5):e512-e519. PubMed ID: 36049186 [TBL] [Abstract][Full Text] [Related]
43. Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence. Jensen B; Chen J; Furnish T; Wallace M Curr Pain Headache Rep; 2015 Oct; 19(10):50. PubMed ID: 26325482 [TBL] [Abstract][Full Text] [Related]
44. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands. Davis MP Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296 [TBL] [Abstract][Full Text] [Related]
45. In patients with chronic neuropathic pain, cannabinoids improve sleep and reduce pain vs. placebo. Kim J Ann Intern Med; 2023 May; 176(5):JC57. PubMed ID: 37126815 [TBL] [Abstract][Full Text] [Related]
46. Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews. Häuser W; Petzke F; Fitzcharles MA Eur J Pain; 2018 Mar; 22(3):455-470. PubMed ID: 29034533 [TBL] [Abstract][Full Text] [Related]
49. Nonopioid versus opioid agents for chronic neuropathic pain, rheumatoid arthritis pain, cancer pain and low back pain. Noori SA; Aiyer R; Yu J; White RS; Mehta N; Gulati A Pain Manag; 2019 Mar; 9(2):205-216. PubMed ID: 30681031 [TBL] [Abstract][Full Text] [Related]
50. [Assessment and Strategy for Nociceptive Pain in Cancer]. Osawa G; Aruga E Gan To Kagaku Ryoho; 2017 Apr; 44(4):278-282. PubMed ID: 28428504 [TBL] [Abstract][Full Text] [Related]
51. An Overview of Pharmacologic Management of Chronic Pain. Beal BR; Wallace MS Med Clin North Am; 2016 Jan; 100(1):65-79. PubMed ID: 26614720 [TBL] [Abstract][Full Text] [Related]
52. [The cannabinoid system and pain: towards new drugs?]. Beltramo M J Soc Biol; 2009; 203(1):99-106. PubMed ID: 19358815 [TBL] [Abstract][Full Text] [Related]
53. Innovative Opioid Peptides and Biased Agonism: Novel Avenues for More Effective and Safer Analgesics to Treat Chronic Pain. Bedini A; Spampinato S Curr Med Chem; 2018; 25(32):3895-3916. PubMed ID: 28215164 [TBL] [Abstract][Full Text] [Related]
54. Is there any clinically relevant cannabinoid-induced analgesia? Kraft B Pharmacology; 2012; 89(5-6):237-46. PubMed ID: 22507873 [No Abstract] [Full Text] [Related]
55. Allodynia Lowering Induced by Cannabinoids and Endocannabinoids (ALICE). Luongo L; Starowicz K; Maione S; Di Marzo V Pharmacol Res; 2017 May; 119():272-277. PubMed ID: 28237514 [TBL] [Abstract][Full Text] [Related]
56. Addiction and pain medicine. Gourlay D Pain Res Manag; 2005; 10 Suppl A():38A-43A. PubMed ID: 16237481 [TBL] [Abstract][Full Text] [Related]
57. Cannabinoids and Pain: Sites and Mechanisms of Action. Starowicz K; Finn DP Adv Pharmacol; 2017; 80():437-475. PubMed ID: 28826543 [TBL] [Abstract][Full Text] [Related]
58. Involvement of the endocannabinoid system in osteoarthritis pain. La Porta C; Bura SA; Negrete R; Maldonado R Eur J Neurosci; 2014 Feb; 39(3):485-500. PubMed ID: 24494687 [TBL] [Abstract][Full Text] [Related]
59. Mechanisms and clinical management of pain. Stump PR; Dalben Gda S Braz Oral Res; 2012; 26 Suppl 1():115-9. PubMed ID: 23318753 [TBL] [Abstract][Full Text] [Related]